These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15035249)

  • 1. A pilot seminar on ethical issues in clinical trials for cancer researchers in Vietnam.
    Love RR; Fost N
    IRB; 2003; 25(6):8-10. PubMed ID: 15035249
    [No Abstract]   [Full Text] [Related]  

  • 2. The ethics of clinical research in developing countries.
    Brunet-Jailly J
    IRB; 1999; 21(5):8-11. PubMed ID: 12625349
    [No Abstract]   [Full Text] [Related]  

  • 3. How to ensure clinical trial sensitivity in psychotropic drug development: a case study.
    Videla S; Sust M; Fresquet A; Villoria J
    Clin Ther; 2005 Feb; 27(2):252-4. PubMed ID: 15811489
    [No Abstract]   [Full Text] [Related]  

  • 4. Placebo controls: scientific and ethical issues.
    Kowalski CJ
    Am J Bioeth; 2002; 2(2):33-4. PubMed ID: 12189073
    [No Abstract]   [Full Text] [Related]  

  • 5. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A
    Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
    [No Abstract]   [Full Text] [Related]  

  • 6. Subject indifference and the justification of placebo-controlled trials.
    Veatch RM
    Am J Bioeth; 2002; 2(2):12-3. PubMed ID: 12189061
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic beneficence and placebo controls.
    Ackerman TF
    Am J Bioeth; 2002; 2(2):21-2. PubMed ID: 12189065
    [No Abstract]   [Full Text] [Related]  

  • 8. Is the placebo powerless?
    Einarson TE; Hemels M; Stolk P
    N Engl J Med; 2001 Oct; 345(17):1277; author reply 1278-9. PubMed ID: 11680456
    [No Abstract]   [Full Text] [Related]  

  • 9. Toward rapproachment in the placebo control debate. A calculated compromise of power.
    Leon AC; Solomon DA
    Eval Health Prof; 2003 Dec; 26(4):404-14. PubMed ID: 14631611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avoiding a Jekyll-and-Hyde approach to the ethics of clinical research and practice.
    Lemmens T; Miller PB
    Am J Bioeth; 2002; 2(2):14-7. PubMed ID: 12189062
    [No Abstract]   [Full Text] [Related]  

  • 11. No way to treat a patient: tens of thousands of people have been subjected to unnecessary drug trials.
    Matthews R
    New Sci; 2005 Jul 9-15; 187(2507):19. PubMed ID: 16178106
    [No Abstract]   [Full Text] [Related]  

  • 12. Patient page. The placebo effect.
    Friedman JH; Dubinsky R
    Neurology; 2008 Aug; 71(9):e25-6. PubMed ID: 18725586
    [No Abstract]   [Full Text] [Related]  

  • 13. Is the placebo powerless?
    Kupers R
    N Engl J Med; 2001 Oct; 345(17):1278; author reply 1278-9. PubMed ID: 11680457
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ethical problems of the clinical placebo use].
    Engelhardt K
    Dtsch Med Wochenschr; 2004 Sep; 129(37):1939-42. PubMed ID: 15372375
    [No Abstract]   [Full Text] [Related]  

  • 15. Is a placebo-controlled surgical trial an oxymoron?
    Boyle K; Batzer FR
    J Minim Invasive Gynecol; 2007; 14(3):278-83. PubMed ID: 17478356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placebo-controlled studies in rheumatoid arthritis: ethical issues.
    Stein CM; Pincus T
    Lancet; 1999 Jan; 353(9150):400-3. PubMed ID: 9950461
    [No Abstract]   [Full Text] [Related]  

  • 17. Are concerns about the ethics of placebos a stalking horse for other issues?
    Healy D
    Am J Bioeth; 2002; 2(2):17-9. PubMed ID: 12189063
    [No Abstract]   [Full Text] [Related]  

  • 18. Debate about placebos points to issue surrounded by many shades of grey.
    Baer N
    CMAJ; 1996 Nov; 155(10):1475-6. PubMed ID: 8943938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harmful effects of the placebo-controlled design.
    Berthelot JM; Glemarec J; Lopes L; Guillot P; Maugars Y; Prost A
    Rev Rhum Engl Ed; 1998 Jan; 65(1):41-3. PubMed ID: 9523385
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence and factors associated with use of placebo control groups in randomized controlled trials in psoriasis: a cross-sectional study.
    Katz KA; Karlawish JH; Chiang DS; Bognet RA; Propert KJ; Margolis DJ
    J Am Acad Dermatol; 2006 Nov; 55(5):814-22. PubMed ID: 17052487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.